Skip to main content
ALKS
NASDAQ Life Sciences

Alkermes Posts Q3 2026 Results, Call Set for 8:00 a.m. ET

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$45.5
Mkt Cap
$7.531B
52W Low
$27
52W High
$55.67
52W Position info
69% above low
Off High info
18% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ALKS sits 69% above its 52-week low of $27.

Summary

Alkermes released third-quarter 2026 results for the period ended September 30, with revenue beating expectations on LUMRYZ growth. The press release carries no revenue, EPS, or guidance figures — the numbers sit in the linked release and presentation on the investor site. The quarter is the first full comparison point after Q2 revenue jumped 27% to $496 million with LUMRYZ added, while acquisition-related costs held net income to $0.5 million and full-year GAAP guidance was widened. Management discusses the results and gives a business update on the 8:00 a.m. ET call today, so the substance lands there rather than in this headline.

At the time of this announcement, ALKS was trading at $45.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5B. The 52-week trading range was $27.00 to $55.67. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ALKS - Latest Insights

ALKS
Nov 12, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.69
Real-time Price: $45.50 info
Change: -$2.19 (-5%) info
Market Cap: $7.552B info
ALKS
Nov 03, 2026, 9:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $45.35
Real-time Price: $45.50 info
Change: +$0.150 (+0.33%) info
Market Cap: $7.552B info
ALKS
Sep 21, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.45
Real-time Price: $45.50 info
Change: +$2.05 (+5%) info
Market Cap: $7.552B info
ALKS
Aug 03, 2026, 4:08 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $49.53
Real-time Price: $45.50 info
Change: -$4.03 (-8%) info
Market Cap: $7.552B info
ALKS
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $49.51
Real-time Price: $45.50 info
Change: -$4.01 (-8%) info
Market Cap: $7.552B info